deacetylase LpxC inhibitors (Chiron)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedeacetylase LpxC inhibitors (Chiron)
Drug Alias NameCHIR-090
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChiron Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiron Corp
Active IndicationsN/A
Inactive IndicationsGram-Negative Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A